T. Rowe Price Associates, Inc. 13D and 13G filings for Praxis Precision Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | T. Rowe Price Associates, Inc. | 1,003,545 4.800% | -116,535 (-10.40%) | Filing |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | T. Rowe Price Associates, Inc. | 1,120,080 6.300% | 1,120,080 (New Position) | Filing |